Endonovo Therapeutics Inc ENDV
$0.00 $0.00
Last Updated: Aug 21, 12:00 AM·OOTC
Pricing for US stocks is delayed by 24 hours
ENDV Shariah Compliance
Screening Methodology: AAOIFI
As of August 2026, Endonovo Therapeutics Inc is classified as not halal.
NOT HALAL
Report Source: undefined Quarter Report
Endonovo Therapeutics Inc. Stock Analysis ENDV
United States Health Care Nano Cap Endonovo Therapeutics, Inc. is a biotechnology company, which engages in the development, manufacture, and distribution of medical devices focused on the rapid healing of wounds and reduction of pain, edema, and inflammation on and in the human body. The company is headquartered in Woodland Hills, California and currently employs 0 full-time employees. The company went IPO on 2012-03-09. The firm is focused on developing bioelectronic devices and cell therapies for regenerative medicine and is a commercial-stage developer of non-invasive wearable Electroceuticals therapeutic devices. The firm's portfolio of commercial and clinical-stage wearable Electroceuticals therapeutic devices addresses wound healing, pain, post-surgical pain and edema, cardiovascular disease, chronic kidney disease, and Central Nervous System (CNS) disorders, including traumatic brain injury (TBI), acute concussions, post- concussion syndrome, and multiple sclerosis. Its non-invasive Electroceutical therapeutic device, SofPulse, uses pulsed short-wave radiofrequency at approximately 27.12 megahertz (MHz) used for the palliative treatment of soft tissue injuries, and post-operative pain and edema, as well as for the treatment of chronic wounds. The company offers an alternative, non-opioid treatment through its Electroceuticals systems.
Endonovo Therapeutics Inc (ENDV) Chart
Financial Metrics & Statements of Endonovo Therapeutics Inc (ENDV)
FAQ's for Endonovo Therapeutics Inc (ENDV)
- As of August 2026, Endonovo Therapeutics Inc ENDV is classified as not halal according to Musaffa’s Shariah screening methodology. This classification is based on an assessment of the company’s business activities and financial ratios against Islamic investment guidelines.
- A stock is Shariah-compliant if the company operates in permissible business activities and meets Islamic financial screening thresholds. Musaffa analyzes Endonovo Therapeutics Inc using these criteria to determine its compliance status.
- Muslim investors may consider investing in Endonovo Therapeutics Inc if it meets Shariah compliance standards. Investors typically review the company’s business activities, debt levels, and non-permissible income before making a decision.
- Musaffa determines the Shariah status of Endonovo Therapeutics Inc by analyzing whether the company’s core business operations are permissible and whether its financial ratios fall within accepted Islamic thresholds.
- The Shariah compliance status of Endonovo Therapeutics Inc may be updated periodically when new financial statements, earnings reports, or business activity information become available.
- Yes. A stock that is currently Shariah-compliant may become non-compliant if the company’s financial ratios exceed Shariah thresholds or its business activities change.
- You can check the latest Shariah compliance status of Endonovo Therapeutics Inc on Musaffa’s stock page, where screening results and key financial indicators are updated to help Muslim investors make informed decisions.
Alternate Halal Stocks for Endonovo Therapeutics Inc (ENDV)
Related Halal Stocks are Shariah-compliant companies that align with Islamic investment principles, avoiding prohibited industries like alcohol, gambling, and interest-based finance.
